Tildrakizumab: A Review of Phase II and III Clinical Trials.

Kolli SS, Gabros SD, Pona A, Cline A, Feldman SR. Tildrakizumab: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2019 04; 53(4):413-418.

View in: PubMed

subject areas

Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Dose-Response Relationship, Drug
Humans
Interleukin-23 Subunit p19
Psoriasis
Treatment Outcome

authors with profiles

Steven R. Feldman MD, PhD